• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of factors contributing to the progression of renal impairment based on single nucleotide polymorphism of uric acid transporter

Research Project

Project/Area Number 18K08224
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 53040:Nephrology-related
Research InstitutionTokyo University of Pharmacy and Life Science

Principal Investigator

Ichida Kimiyoshi  東京薬科大学, 薬学部, 教授 (80183169)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
KeywordsCKD / ABCG2 / 腎機能 / 尿酸トランスポーター / 尿酸 / 一塩基多型 / 慢性腎臓病 / 腎不全
Outline of Final Research Achievements

Hyperuricemia is a risk factor for the development of renal disease or a facilitator of renal impairment, and to clarify the effect of ABCG2 function on the renal function decline, we evaluated the single nucleotide polymorphisms Q126X and Q141K in the ABCG2 gene. In a study of 276 CKD patients, there was a trend toward accelerated eGFR decline with presumed ABCG2 functional decline in the CKD stage G3 group. A retrospective cohort study of 1885 healthy subjects (eGFR >60 mL/min/1.73m2) also showed that estimated ABCG2 functional decline significantly reduced renal function over a longer time course of 9-10 years. Furthermore, the results were similar when matched by propensity score for age, gender (males only), eGFR, BMI, and serum uric acid level, indicating the involvement of ABCG2 in renal function independent of serum uric acid level.

Academic Significance and Societal Importance of the Research Achievements

ABCG2の機能低下が高尿酸血症を引き起こすと同時に、高尿酸血症を介さずにも腎障害の進行を促進することが明らかになった。さらに高尿酸血症に著しいABCG2機能低下を合併すると、腎障害の進行は促進されることも明らかになった。ABCG2の機能低下を来す一塩基多型Q126XとQ141Kの頻度は高いことから、将来的には高尿酸血症患者のABCG2の一塩基多型を調べることにより、より腎障害の進行のリスクの高い患者に絞って、その他のリスクの管理や生活指導を行えるようになることが期待される。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (5 results)

All 2021 2020 2019

All Presentation (5 results) (of which Int'l Joint Research: 1 results)

  • [Presentation] 健常人におけるABCG2の腎保護的機能の解明2021

    • Author(s)
      大橋勇紀 、中野知子、栗山哲、市田公美
    • Organizer
      第54回日本痛風・尿酸核酸学会総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 健常集団における腎機能とABCG2機能低下の関係2021

    • Author(s)
      大橋勇紀 、栗山哲、市田公美
    • Organizer
      第64回日本腎臓学会学術総会
    • Related Report
      2020 Annual Research Report
  • [Presentation] Decreased ABCG2 Activity accelerates the Age-Dependent Decline in Renal Function2021

    • Author(s)
      Yuki Ohashi, Satoru Kuriyama, Kimiyoshi Ichida
    • Organizer
      The 19th Symposium on Purine and Pyrimidine Metabolism in Man
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research
  • [Presentation] CKD患者の腎機能低下に及ぼす尿酸トランスポーターABCG2の保護的役割の解明 (第2報)2020

    • Author(s)
      大橋 勇紀
    • Organizer
      第53回日本痛風・尿酸核酸学会総会
    • Related Report
      2019 Research-status Report
  • [Presentation] CKD患者の腎機能低下に及ぼす尿酸トランスポーターABCGの保護的役割の解明(第2報)2019

    • Author(s)
      増本 翔
    • Organizer
      第52回日本痛風・核酸代謝学会総会
    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi